According to a foreign news agency, the results of the initial lab showed that the vaccine developed by Cyanovik Biotech Limited, the most widely used in the world, does not provide enough antibodies in two doses to neutralize the omecron variant and Boosters will be needed to improve safety. A statement from a team of